Zhongshun Jierou (002511) Interim Report comment： steady revenue growth, performance elasticity released as scheduled
Zhongshun Jierou (002511) Interim Report comment: steady revenue growth, performance elasticity released as scheduled Key points of the report Event description Zhongshun Jierou released the semi-annual report, and the company achieved revenue 31 in 2019H1. 7.2 billion, an increase of
China National Travel Service (601888): 18 Years of Main Business Profitability Outstanding 19Q1 Performance Exceeds Market Expectations Brief account of performance: 2018: Realized revenue of 470. 07 ppm / + 66. 21%, net profit attributable to mother 30. 9.4 billion
The fund's highest increase during the year was nearly 60%. Last year's champion Liu Gezhen fell out of the top 20 (table) Earnings "exploded"! During the year, the fund's highest increase was nearly 60%. Last year's champion Liu Gezhen fell
Yanghe Co. (002304): Proactively adjust pressure in the province and try to return to healthy development Event: Yanghe announced the third quarter report of 2019, and the revenue for the first three quarters was 210. 980,000 yuan, ten years +0.
"Poison eggs" spilled over in response to crisis meeting of legal authorities in 北京夜网 12 German states China News Agency, Berlin, August 3 (Reporter Peng Dawei): A large number of eggs imported from the Netherlands recently exposed to the contamination
Dongshan Precision (002384): 5G base stations with strong FPC momentum are ready Company status We recently invited Dongshan Precision Joint Venture to communicate with investors in Shanghai. Optimistic about Dongshan Precision benefits from: 1) Apple 's mobile phones, accessories and
Sany Heavy Industry (600031) 2019 Annual Report Performance Preview Comment: High Performance Increases on Schedule and Increases Profit Forecast for 2020 Event: The company issued a 2019 performance forecast, which is expected to achieve a net profit of 108. 0-118.
East China Pharmaceutical (000963) quarterly report comment: performance continues to exceed expectations Recently, East China Pharmaceutical announced the first quarter report of 2019, which reported a preliminary operating income of 97. 5.0 billion, an annual increase of 23. 84%, achieving
Songdu Shares (600077): Achieving a trough in performance and optimizing financial structure Investment highlights: The company announced its 2018 annual report and achieved revenue of 45. 900 million, a year-on-year increase of 67%; net profit4. 1 billion, an increase of
Changsha Bank (601577): Deposit growth picks up and asset quality improves Event: On October 30, Changsha Bank disclosed three quarterly reports.In the third quarter of 19, operating income was 124.02 billion, up + 22.0%, which belongs to the net profit